Abner Herrman & Brock’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,108
Closed -$451K 131
2019
Q3
$451K Sell
7,108
-62
-0.9% -$4.05K 0.07% 80
2019
Q2
$484K Hold
7,170
0.07% 79
2019
Q1
$466K Hold
7,170
0.07% 78
2018
Q4
$448K Hold
7,170
0.08% 74
2018
Q3
$554K Sell
7,170
-2,006
-22% -$152K 0.08% 79
2018
Q2
$650K Sell
9,176
-2,300
-20% -$162K 0.1% 76
2018
Q1
$865K Buy
11,476
+1,840
+19% +$146K 0.14% 74
2017
Q4
$690K Sell
9,636
-1,394
-13% -$106K 0.12% 78
2017
Q3
$894K Buy
11,030
+828
+8% +$63.3K 0.16% 72
2017
Q2
$722K Hold
10,202
0.14% 79
2017
Q1
$693K Buy
10,202
+50
+0.5% +$3.52K 0.14% 71
2016
Q4
$772K Sell
10,152
-103
-1% -$7.66K 0.16% 69
2016
Q3
$811K Sell
10,255
-219
-2% -$17.8K 0.18% 66
2016
Q2
$903K Sell
10,474
-420
-4% -$37.3K 0.21% 64
2016
Q1
$1M Buy
10,894
+493
+5% +$44.5K 0.25% 62
2015
Q4
$1.05M Hold
10,401
0.54% 48
2015
Q3
$1.04M Buy
10,401
+144
+1% +$16K 0.56% 47
2015
Q2
$1.16M Buy
10,257
+96
+0.9% +$10.5K 0.58% 46
2015
Q1
$997K Hold
10,161
0.51% 52
2014
Q4
$958K Sell
10,161
-319
-3% -$33K 0.49% 47
2014
Q3
$1.12M Hold
10,480
0.33% 59
2014
Q2
$869K Hold
10,480
0.26% 58
2014
Q1
$743K Hold
10,480
0.24% 61
2013
Q4
$768K Buy
10,480
+348
+3% +$24.2K 0.27% 61
2013
Q3
$637K Sell
10,132
-1,174
-10% -$70.2K 0.42% 61
2013
Q2
$580K Buy
+11,306
New +$589K 0.25% 67

Other funds holding GILD

Abner Herrman & Brock's GILD Position: Q4 2019 in Review

Abner Herrman & Brock sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 7,108 shares — an estimated $451K sold.

Abner Herrman & Brock first reported a position in GILD in Q2 2013 and held it in 26 quarters. The position peaked at $1.16M in Q2 2015. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Abner Herrman & Brock reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
  • Abner Herrman & Brock sold 7,108 Gilead Sciences shares in Q4 2019, an estimated $451K.
  • Abner Herrman & Brock first reported a position in Gilead Sciences in Q2 2013 and held it in 26 quarters.
  • Abner Herrman & Brock's Gilead Sciences position peaked at $1.16M in Q2 2015.
  • 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Abner Herrman & Brock's 13F filing for Q4 2019, filed 10 Jan 2020.